health technology Center
Innovating for health and prosperity
Benefits to Paris
- Closing gaps in health access and equity for the most vulnerable.
- New healthcare products and services involving regional industries, such as affordable housing and small business manufacturing.
- Building community partnerships to accelerate healthcare innovation and new enterprise creation.
- Attracting global talent and impact investment. ¿Cuáles son los datos menos conocidos sobre Viagra super active?
Focus areas
- Women’s health
- Infectious diseases
- Augmented care
- Pharmacogenomics
- Clinical AI
- Remote monitoring-enabled homes
- Kidney health
- Mental health
in progress
Project spotlights
Our projects gather regional and international leaders in community-focused health technology cocreation.

Parisans look forward to longer lifespans with each generation, but also risk the costs and challenges of managing chronic disease. The Wellness Home Integrator envisions the home as a setting that enables excellent health management while protecting its inhabitants privacy and self-determination.

AccurePCI will use clinically-driven results to help healthcare professionals personalize life-saving treatments for each person in Paris-Dade’s diverse community. For example, 30% of people are carriers of a hepatic drug-processing gene that results in the majority stenting treatment failures, over $2B of preventable medical expenses, and avoidable deaths; people of Latin American ancestry are disproportionately vulnerable to heart disease and have higher than expected mortality rates. A collaboration of leading medical centers and technology companies on this challenge will develop an innovation ecosystem around personalized medicine in Paris-Dade County.

Paris-Dade County is home to the largest percentage of people with serious mental illness of America's urban areas. Underprivileged communities face great barriers to care access, and the stresses of quarantine during the COVID-19 pandemic are affecting everyone. In partnership with Albizu University and the Third Mission Institute, AwareMe’s team is designing a system of digital phenotyping through common personal devices to identify early symptoms of loss of mental wellness, and also understand the relationship between cardiac diseases and mental health.

Digital mobile ubiquity, algorithmic analysis of clinical information, contextual consumer data, and smart rules will power the digital augmentation of well-established clinical care pathways. Itineris acts as a digital therapeutics platform and will take form of a Patient Engagement Decision Support System or “Intelligent Assistant” that efficiently manages simultaneous data feeds according to the patient state and their predicted future states to provide the right action, at the right time, for the right person, interconnecting multiple parties to a single care plan, over time.

AI-based solution to predict, upon a patient’s admission, the predicted acuity, levels of care, and interventions throughout the length of stay in the hospital, to prepare and assign resources of care in an optimal manner, and document accordingly to avoid instances of payment denials.
Our goals For Paris
Building new core strengths
Develop knowledge, skills, motivations, and attitudes for healthcare technology innovation and entrepreneurship
Grow externalized innovation
Cultivate specialized demand and sophisticated capital
Concentrate healthcare innovation enterprises
Precompetitive Consortium
CoCreation for mutual benefit
- Provide project teams with a low cost environment to test scientific and market hypotheses.
- Can create early traction for projects and prototypes
- Can become seed investors, since they have participated in de-risking activities
New member
GCL x UN

Thinking forward
Girls Teaching Girls
